PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics
Retrieved on:
Wednesday, May 12, 2021
b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.
Key Points:
- b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.
- Among others, an automated system that produces in-house PET radiopharmaceuticals and linear accelerators for non-destructive testing (high-energy radiography), and radiotherapy.
- In 2019, nearly 3,800 scientific papers were published by CEA researchers, three-quarters of which were the result of international collaboration.
- The CEA draws on all this knowledge to carry out its other activities.\nFor more information about PMB and CEA, please visit www.pmb-alcen.com / www.cea.fr\nAdditional information about iMiGiNE can be found at www.imigine.com or follow PMB-Alcen on LinkedIn.\n'